We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nexeon MedSystems, Inc. (NXNN) Flat As Market Gains: What You Should Know
Read MoreHide Full Article
Nexeon MedSystems, Inc. (NXNN - Free Report) closed the most recent trading day at $5.95, making no change from the previous trading session. This change lagged the S&P 500's 3.43% gain on the day. Meanwhile, the Dow gained 3.29%, and the Nasdaq, a tech-heavy index, added 4.26%.
Wall Street will be looking for positivity from NXNN as it approaches its next earnings report date. This is expected to be April 4, 2019. On that day, NXNN is projected to report earnings of -$0.82 per share, which would represent year-over-year growth of 41.43%. Our most recent consensus estimate is calling for quarterly revenue of $1.84 million, down 15.05% from the year-ago period.
It is also important to note the recent changes to analyst estimates for NXNN. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 1.01% lower within the past month. NXNN is currently a Zacks Rank #4 (Sell).
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 96, which puts it in the top 38% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Nexeon MedSystems, Inc. (NXNN) Flat As Market Gains: What You Should Know
Nexeon MedSystems, Inc. (NXNN - Free Report) closed the most recent trading day at $5.95, making no change from the previous trading session. This change lagged the S&P 500's 3.43% gain on the day. Meanwhile, the Dow gained 3.29%, and the Nasdaq, a tech-heavy index, added 4.26%.
Wall Street will be looking for positivity from NXNN as it approaches its next earnings report date. This is expected to be April 4, 2019. On that day, NXNN is projected to report earnings of -$0.82 per share, which would represent year-over-year growth of 41.43%. Our most recent consensus estimate is calling for quarterly revenue of $1.84 million, down 15.05% from the year-ago period.
It is also important to note the recent changes to analyst estimates for NXNN. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 1.01% lower within the past month. NXNN is currently a Zacks Rank #4 (Sell).
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 96, which puts it in the top 38% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.